Provided by Tiger Trade Technology Pte. Ltd.

Core Assets of Southward Funds

972.044
-21.886-2.20%
Number of Gainers:7
Number of Losers:59
Number of Flat:1
PE:- -
High:987.809
Open:987.809
Low:966.852
Close:993.930
Volume:981.66M
Turnover:29.44B
Market Cap:13.15T
Float Cap:12.22T

Loading ...

Shunde Joins Forces with China Telecom to Build a Benchmark for Digital Economy Development in the Greater Bay Area

Deep News
·
Sep 25

Citi Reiterates Buy Rating on Tencent Holdings with HK$765 Target Price

Deep News
·
Sep 25

Macau Casino Stocks Extend Losses as Market Watches Holiday Tourism; Citi Flags Unusually Quiet Betting Sentiment

Stock News
·
Sep 25

Blind Box Becomes Transparent Box? Xiaomi 18 Pro Rear Screen Tricked, Boxes Identified Without Opening

Deep News
·
Sep 25

CMSC International Keeps Geely Auto Target Price at HK$34.2 and Reiterates "Overweight" Rating

Stock News
·
Sep 25

Hong Kong-listed Mainland Property Stocks Slide as Mortgage Subsidy Hopes Fade, Vanke Falls Over 5%

Deep News
·
Sep 25

Orient Securities Keeps Buy Rating on Poly Property Services, Lowers Target Price to HK$38.50

Stock News
·
Sep 25

Citi Says Goertek and Sunny Optical Set to Gain from Meta VR Glasses

Deep News
·
Sep 25

Regulator Clarifies Insurers' Hong Kong Stock Connect ETF Investment Rules; Crealights' Southbound Stake Rises to 4.2%

Stock News
·
Sep 25

Xiaomi Redesigns Large Model Architecture as Agents Tackle Long Tasks

Deep News
·
Sep 25

Lianshan Government Partners with China Mobile Qingyuan Branch and Guangdong Broadcasting Network Lianshan Branch to Build Digital Lianshan

Deep News
·
Sep 24

Yu Chengdong Says Seres Voluntarily Proposed to Lead AITO; Today's Financial Briefing

Deep News
·
Sep 24

The Capital Group Companies, Inc. Trims Stake in ASMPT (00522) by 961,700 Shares at About HK$173.11 Each

Stock News
·
Sep 24

WuXi Biologics - Wuxi Mashan Site Passes Two-Week FDA Gmp Inspection

THOMSON REUTERS
·
Sep 24

Hansoh Pharma's Application for Osteosarcoma Drug Accepted in China

MT Newswires Live
·
Sep 24

Hansoh Pharma's HS-20093 Osteosarcoma Marketing Application Accepted by China's NMPA

Stock News
·
Sep 24

Hansoh Pharmaceutical - Biologics License Application of Risvutatug Rezetecan for Injection (Hs-20093) for Osteosarcoma Accepted by Nmpa

THOMSON REUTERS
·
Sep 24

Lin Zhong Resigns as Chairman of ES Services (01995) to Focus Fully on CIFI's Debt Restructuring and Transformation

Stock News
·
Sep 24

Yadea H1 2026: Dual Decline in Revenue and Profit, E-Bike Sales Down 38%, Smart Features Questioned as Far Behind Niu and Segway-Ninebot, Receivables Surge 114%

Deep News
·
Sep 24

Electric Two-Wheeler Interim Reports: Performance Divergence Deepens as Ninebot Overtakes Aima in Revenue While Yadea, Aima, Luyuan and Xinri All Post Dual Declines

Deep News
·
Sep 24